These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8820287)

  • 1. Extemporaneous preparation of antibiotic ophthalmic solutions.
    Hammond RW; Walker TP; McClung HF; Edmondson W
    J Am Pharm Assoc (Wash); 1996 Mar; NS36(3):206-9. PubMed ID: 8820287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical vs subconjunctival treatment of bacterial corneal ulcers.
    Baum J; Barza M
    Ophthalmology; 1983 Feb; 90(2):162-8. PubMed ID: 6856253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale for adjunctive topical corticosteroids in bacterial keratitis.
    Hindman HB; Patel SB; Jun AS
    Arch Ophthalmol; 2009 Jan; 127(1):97-102. PubMed ID: 19139348
    [No Abstract]   [Full Text] [Related]  

  • 4. Topical treatment with nerve growth factor for corneal neurotrophic ulcers.
    Baum J
    Surv Ophthalmol; 1999; 43(4):372-3. PubMed ID: 10025520
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group.
    Hyndiuk RA; Eiferman RA; Caldwell DR; Rosenwasser GO; Santos CI; Katz HR; Badrinath SS; Reddy MK; Adenis JP; Klauss V
    Ophthalmology; 1996 Nov; 103(11):1854-62; discussion 1862-3. PubMed ID: 8942881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of bacterial corneal ulcers with concentrated antibiotic eye drops.
    Chaudhuri PR; Godfrey B
    Trans Ophthalmol Soc U K (1962); 1982 Apr; 102 (Pt 1)():11-14. PubMed ID: 6963041
    [No Abstract]   [Full Text] [Related]  

  • 7. The case against the use of steroids in the treatment of bacterial keratitis.
    Cohen EJ
    Arch Ophthalmol; 2009 Jan; 127(1):103-4. PubMed ID: 19139349
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5%, a new topical fluoroquinolone.
    Stroman DW; Dajcs JJ; Cupp GA; Schlech BA
    Surv Ophthalmol; 2005 Nov; 50 Suppl 1():S16-31. PubMed ID: 16257308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current diagnosis and treatment of corneal ulcers.
    Benson WH; Lanier JD
    Curr Opin Ophthalmol; 1998 Aug; 9(4):45-9. PubMed ID: 10387468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of topical gatifloxacin with ciprofloxacin, amikacin, and clarithromycin in the treatment of experimental Mycobacterium chelonae keratitis.
    Hyon JY; Joo MJ; Hose S; Sinha D; Dick JD; O'Brien TP
    Arch Ophthalmol; 2004 Aug; 122(8):1166-9. PubMed ID: 15302657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community practice patterns for bacterial corneal ulcer evaluation and treatment.
    Park J; Lee KM; Zhou H; Rabin M; Jwo K; Burton WB; Gritz DC
    Eye Contact Lens; 2015 Jan; 41(1):12-8. PubMed ID: 25536529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of two chondroitin sulfate ophthalmic solutions in the therapy of spontaneous chronic corneal epithelial defects and ulcerative keratitis associated with bullous keratopathy in dogs.
    Ledbetter EC; Munger RJ; Ring RD; Scarlett JM
    Vet Ophthalmol; 2006; 9(2):77-87. PubMed ID: 16497231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of topical fixed-combination fortified vancomycin-amikacin (VA solution) to conventional separate therapy in the treatment of bacterial corneal ulcer.
    Chiang CC; Lin JM; Chen WL; Chiu YT; Tsai YY
    Eye (Lond); 2009 Feb; 23(2):294-8. PubMed ID: 18188174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of topical gatifloxacin 0.3% and ciprofloxacin 0.3% for the treatment of bacterial keratitis.
    Parmar P; Salman A; Kalavathy CM; Kaliamurthy J; Prasanth DA; Thomas PA; Jesudasan CA
    Am J Ophthalmol; 2006 Feb; 141(2):282-286. PubMed ID: 16458681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of bacterial ulcers of the cornea in the rabbit: a comparison of administration by eye drops and subconjunctival injections.
    Baum J
    Trans Am Ophthalmol Soc; 1982; 80():369-90. PubMed ID: 6763800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pattern and antibiotic sensitivity of bacterial corneal ulcers in Kano, Northern Nigeria.
    Abubakar UM; Lawan A; Muhammad I
    Ann Afr Med; 2018; 17(3):151-155. PubMed ID: 30185685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory and healing properties of nerve growth factor in immune corneal ulcers with stromal melting.
    Lambiase A; Bonini S; Aloe L; Rama P; Bonini S
    Arch Ophthalmol; 2000 Oct; 118(10):1446-9. PubMed ID: 11030834
    [No Abstract]   [Full Text] [Related]  

  • 18. Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo.
    Caballero AR; Marquart ME; O'Callaghan RJ; Thibodeaux BA; Johnston KH; Dajcs JJ
    Curr Eye Res; 2006 Jan; 31(1):23-9. PubMed ID: 16421016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous lavage in (chemical) corneal lesions.
    La Lau C
    Doc Ophthalmol; 1979 Mar; 46(2):215-8. PubMed ID: 477477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pilot study of a new matrix therapy agent (RGTA OTR4120) in treatment-resistant corneal ulcers and corneal dystrophy].
    Chebbi CK; Kichenin K; Amar N; Nourry H; Warnet JM; Barritault D; Baudouin C
    J Fr Ophtalmol; 2008 May; 31(5):465-71. PubMed ID: 18641578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.